數位病理學市場規模、佔有率、成長分析（按產品、類型、應用、最終用途和地區）- 2025-2032 年產業預測

全球數位病理檢測市場規模預計在 2023 年達到 9 億美元，到 2032 年將達到 17.7 億美元，預計在預測期內（2025-2032 年）的複合年成長率為 7.8%。

由於癌症和心血管疾病發病率的不斷上升，需要精確的診斷工具，數位病理學市場正在經歷顯著成長。慢性病的增加推動了對該領域主要企業開發的先進數位病理學檢測系統的需求。 Medscape 稱，死亡率的上升與這些疾病有關，為進一步創新提供了動力。數位病理學透過組織宏觀影像和實施影像分析方法來增強調查流程。此外，對遠端病理學解決方案進行遠端評估和即時諮詢的依賴日益增加以及政府資助是推動市場擴張的主要因素。隨著這些技術的發展，它們將促進診斷的改進並創造更有效率的醫療保健環境。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

數位病理學測試市場規模（按產品和複合年成長率）（2025-2032）

• 市場概覽
• 掃描器
  • 明場掃描儀
  • 螢光掃描儀
  • 其他掃描儀
• 軟體
  • 整合軟體
  • StandOne軟體
• 部署模型
  • 雲端基礎模式
  • 本地模型
  • 混合模式
• 儲存系統

數位病理學測試市場規模（按類型和複合年成長率）（2025-2032）

• 市場概覽
• 人體病理學
• 獸醫病理學

數位病理學測試市場規模（按應用和複合年成長率）（2025-2032）

• 市場概覽
• 藥物研發
• 學術研究
• 疾病診斷
  • 癌細胞檢測
  • 其他

數位病理學檢測市場規模（按最終用途和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 生物技術和製藥公司
• 診斷實驗室
• 學術研究所

數位病理學測試市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較比較（2022-2024 年）

主要企業簡介

• Koninklijke Philips NV（Netherlands）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Hamamatsu Photonics KK（Japan）
• Olympus Corporation（Japan）
• PerkinElmer, Inc.（United States）
• 3DHISTECH Ltd.（Hungary）
• Sectra AB（Sweden）
• Visiopharm A/S（Denmark）
• Apollo Enterprise Imaging Corporation（Canada）
• Corista LLC（United States）
• Paige.AI, Inc.（United States）
• Ibex Medical Analytics Ltd.（Israel）
• Indica Labs, Inc.（United States）
• Proscia Inc.（United States）
• Deep Lens Inc.（United States）
• Aiforia Technologies Oyj（Finland）
• OptraSCAN, Inc.（United States）
• Mikroscan Technologies, Inc.（United States）
• Xilis, Inc.（United States）

結論和建議

Global Digital Pathology Market size was valued at USD 0.9 billion in 2023 and is poised to grow from USD 0.97 billion in 2024 to USD 1.77 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The digital pathology market is experiencing significant growth due to the increasing incidence of cancer and cardiovascular diseases, necessitating precise diagnostic tools. The rise in chronic illnesses has heightened the demand for advanced digital pathology systems developed by major players in the field. According to Medscape, an uptick in mortality rates correlates with these conditions, driving further innovation. Digital pathology enhances research pipelines by organizing macroscopic images and implementing image analysis methods. Additionally, government funding, along with the growing reliance on telepathology solutions for remote evaluations and real-time consultations, are key factors propelling market expansion. As these technologies evolve, they facilitate enhanced diagnostics, fostering a more efficient healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Pathology Market Segments Analysis

Global Digital Pathology Market is segmented by Product, Type, Application, End-use and region. Based on Product, the market is segmented into Scanners, Software, Deployment Model and Storage System. Based on Type, the market is segmented into Human Pathology and Veterinary Pathology. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research and Disease Diagnosis. Based on End-use, the market is segmented into Hospitals, Biotech & Pharma Companies, Diagnostic Labs and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Pathology Market

The Global Digital Pathology market is significantly driven by technological advancements including whole-slide imaging (WSI), advanced image analysis tools, and the integration of artificial intelligence (AI). These innovations have revolutionized the field of digital pathology, making it more appealing to healthcare providers by enhancing diagnostic accuracy, boosting operational efficiency, and facilitating automated workflow processes. As a consequence of these developments, digital pathology is becoming an essential component in modern healthcare practices, leading to widespread adoption and contributing to the overall growth of the market. The continuous evolution of these technologies promises to further enhance the capabilities of digital pathology in the future.

Restraints in the Global Digital Pathology Market

The Global Digital Pathology market faces significant constraints due to the complex and labor-intensive nature of integrating existing healthcare IT infrastructures with digital pathology solutions. This challenge is particularly pronounced in institutions that rely on outdated technologies, where compatibility issues and the extensive modifications required can create obstacles to system adoption. These complications can hinder the smooth implementation and optimization of digital pathology workflows, ultimately impeding the overall acceptance of these advanced systems within healthcare organizations and limiting their effectiveness in improving diagnostic processes and patient outcomes.

Market Trends of the Global Digital Pathology Market

The global digital pathology market is witnessing a significant shift towards fully cloud-based solutions, driven by advancements in imaging technology and a growing emphasis on scalable, collaborative, and personalized healthcare. As the demand for eco-friendly diagnostic tools escalates, digital pathology is increasingly being recognized for its ability to facilitate efficient data collection, management, and analysis. The adoption of Whole Slide Imaging (WSI) is a standout trend, enabling pathologists to digitally access and analyze entire tissue slides, significantly improving diagnostic accuracy and workflow efficiency. This market evolution is indicative of a broader move towards innovative healthcare solutions that enhance collaboration and improve patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Digital Pathology Market Size by Product & CAGR (2025-2032)

• Market Overview
• Scanners
  • Brightfield Scanners
  • Fluorescence Scanners
  • Other Scanners
• Software
  • Integarted Software
  • Standone Software
• Deployment Model
  • Cloud-Based Model
  • On-Premise Model
  • Hybrid Model
• Storage System

Global Digital Pathology Market Size by Type & CAGR (2025-2032)

• Market Overview
• Human Pathology
• Veterinary Pathology

Global Digital Pathology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery & Development
• Academic Research
• Disease Diagnosis
  • Cancer Cell Detection
  • Others

Global Digital Pathology Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Biotech & Pharma Companies
• Diagnostic Labs
• Academic & Research Institutes

Global Digital Pathology Market Size & CAGR (2025-2032)

• North America (Product, Type, Application, End-use)
  • US
  • Canada
• Europe (Product, Type, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamamatsu Photonics K.K. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3DHISTECH Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sectra AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Visiopharm A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Enterprise Imaging Corporation (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corista LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Paige.AI, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ibex Medical Analytics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indica Labs, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proscia Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deep Lens Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aiforia Technologies Oyj (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptraSCAN, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mikroscan Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xilis, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations